Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

A cross-disciplinary research team has, for the first time, successfully applied NIR-II (1,000–3,000 nm) fluorescence video ...

A joint research team led by Professors Jaesok Yu, Hoejoon Kim, and Sanghoon Lee of the Department of Robotics and ...

Theranostic programs are expanding rapidly, creating a growing need to understand how institutions implement ...

A large observational study using data from the Breast Cancer Surveillance Consortium suggested that supplemental MRI with or ...

ContrastConnect expands remote virtual radiologist guidance for contrast reactions and medication protocols based on CMS's ...

The White House released a statement on Dec. 1 from President Donald Trump's physician regarding his MRI scan. Here's what to ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that its MEDRAD ® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the ...

Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...

Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...